HOME >> BIOLOGY >> NEWS
Epigenetic activity silences Rb2/P130 gene in lung cancer

b2/p130 gene. Once the drugs or agents disconnect the methyl groups from Rb2/p130, the gene begins to again express itself or function normally."

He likened this methylation/de-methylation phenomenon--which can stop or start the expression of a gene--to a lightswitch which is used to turn a lamp off or on.

Giordano said some of these agents that will de-methylate Rb2 are already available, but have not been previously used because researchers did not know that the lack of expression from the gene was being caused by its methylation.

"Our discovery is providing a smart method to identify novel methylated drugs or agents that can assist in restarting the vital expression of Rb2/p130," he said.

Through the use of a simple genetic (both at DNA and Protein level) test of Rb2 gene and protein from a human tissue sample, said Giordano, scientists could determine if cancerous or pre-cancerous conditions exist because of the epigenetic state of the gene.

"We could develop a potential test which could save many, many people from the ravages of cancer," he said.


'"/>

Contact: Preston M. Moretz
pmoretz@temple.edu
215-204-7476
Temple University
12-Sep-2005


Page: 1 2

Related biology news :

1. Epigenetic studies will provide a better understanding of disease
2. Epigenetics to shape stem cell future
3. Epigenetic drugs, promising for breast cancer treatment
4. New view of cancer: Epigenetic changes come before mutations
5. Prenatal alcohol exposure alters brain activity in the frontal-striatal areas
6. Genes activity points to more lethal subtype of AML
7. Weizmann Institute scientists develop a general control switch for protein activity
8. Slow wave activity during sleep is lower in African-Americans than Caucasians
9. ChemGenex announces publication confirming activity of Ceflatonin in T315I-Positive CML
10. Neuronal activity gives clues to working memory
11. CSHL links activity in brain synapses and developmental abnormalities with schizophrenia gene

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/13/2019)... ... June 13, 2019 , ... Global Clinical and ... the end-to-end clinical and ancillary supply chain management needs of large- and middle-market ... organizations, today announced it will sponsor a summer education program offered by the ...
(Date:6/6/2019)... ... June 05, 2019 , ... MedTech Breakthrough , ... health and medical technology market, announced that it has selected Medacta International’s MySpine® ... award in the 2019 MedTech Breakthrough Awards program. , Medacta® ...
(Date:6/4/2019)... MEMPHIS, Tenn. (PRWEB) , ... June 04, 2019 ... ... in contract manufacturing of orthopedic medical devices, today announced Q1-19 revenues of $31M, ... the industry combined with successful roll-out of strategic investments & operational excellence initiatives ...
Breaking Biology News(10 mins):
(Date:5/15/2019)... ... May 16, 2019 , ... ... a result, food and beverage products rely on these ingredients to create stable ... sounding label declarations. This paradigm shift triggers food formulators to seek out alternatives ...
(Date:5/8/2019)... ... ... Standing at 16.2 hands, Atlas is on the large side for a Quarter Horse. ... among other activities. When loping around a corner in late 2017, Atlas tripped and ... to only being able to walk. Fortunately Atlas’ owner, Kelly, sought the opinion of ...
(Date:5/4/2019)... ... May 03, 2019 , ... Diopsys Inc, the world ... Negative Response vision test, a new full field electroretinography (ffERG) protocol designed ... 6.3 million Americans will have glaucoma, with black Americans having the highest prevalence ...
(Date:5/2/2019)... ... ... Stay on top of current hot topics through free webinars presented by leading ... free, so be sure to register today to save your place! Participate in the ... our upcoming webinars: , CLINICAL TRIALS , May 7 – Oncology Clinical Trials – ...
Breaking Biology Technology:
Cached News: